165 related articles for article (PubMed ID: 8361170)
1. Allograft rejection by T cell receptor transgenic mice.
Bassiri H; Markmann JF; Desai NM; Kim JI; Teh HS; Barker CF
J Surg Res; 1993 May; 54(5):437-44. PubMed ID: 8361170
[TBL] [Abstract][Full Text] [Related]
2. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
3. T cells with dual antigen specificity in T cell receptor transgenic mice rejecting allografts.
Simpson E; Chandler P; Sponaas A; Millrain M; Dyson PJ
Eur J Immunol; 1995 Oct; 25(10):2813-7. PubMed ID: 7589076
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
5. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
6. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells.
Zelenika D; Adams E; Mellor A; Simpson E; Chandler P; Stockinger B; Waldmann H; Cobbold SP
J Immunol; 1998 Aug; 161(4):1868-74. PubMed ID: 9712055
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
9. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
[TBL] [Abstract][Full Text] [Related]
10. A novel model of allograft rejection: immune reconstitution of Rag-1 recipients with 2C transgenic T-cell receptor lymphocytes.
Ninova D; Dean PG; Deeds M; Stegall MD
Transpl Int; 2005 Jan; 18(1):101-10. PubMed ID: 15612991
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
Coulombe M; Yang H; Wolf LA; Gill RG
J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
[TBL] [Abstract][Full Text] [Related]
12. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
13. Anti-LFA-1 antibody postpones T-cell receptor triggering while preserving generation of regulatory T cells in T-cell receptor anti-HY transgenic mice.
Go S; Fleischmann A; Lantz O; Cretolle C; Brousse N; Cerf-Bensussan N; Sarnacki S
Transplantation; 2006 Jul; 82(1):119-26. PubMed ID: 16861951
[TBL] [Abstract][Full Text] [Related]
14. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
15. T cell tolerance and activation to a transgene-encoded tumor antigen.
Antoniou A; McCormick D; Scott D; Yeoman H; Chandler P; Mellor A; Dyson J
Eur J Immunol; 1996 May; 26(5):1094-102. PubMed ID: 8647173
[TBL] [Abstract][Full Text] [Related]
16. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
17. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
[TBL] [Abstract][Full Text] [Related]
18. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
Zhang HG; Su X; Liu D; Liu W; Yang P; Wang Z; Edwards CK; Bluethmann H; Mountz JD; Zhou T
J Immunol; 1999 Feb; 162(3):1423-30. PubMed ID: 9973398
[TBL] [Abstract][Full Text] [Related]
19. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.
Kisielow P; Blüthmann H; Staerz UD; Steinmetz M; von Boehmer H
Nature; 1988 Jun; 333(6175):742-6. PubMed ID: 3260350
[TBL] [Abstract][Full Text] [Related]
20. Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts.
Gill RG; Rosenberg AS; Lafferty KJ; Singer A
J Immunol; 1989 Oct; 143(7):2176-8. PubMed ID: 2506278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
